CD19 and lymphoma: We have previously generated a conditional miR-17~92 transgene (termed miR-17~92 Tg), whose expression can be turned on in B cells by CD19-Cre, and showed that the resulting transgenic mice (TG) developed lymphomas with high penetrance (Jin et al., 2013).